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Introduction:  Group I metabotropic glutamate receptors (mGluR1/mGluR5 subtypes) 
and their key scaffolding protein Homer1b/c are densely expressed in the striatum.  
These receptors are believed to play important roles in the regulation of 
psychostimulant action1.  The psychostimulant amphetamine increases extracellular 
glutamate levels, which in turn activates postsynaptic mGluR1/5 in striatal neurons.  It 
is, however, unclear whether amphetamine has any impact on striatal mGluR1/5 
expression.  In this study, we hypothesized that alterations in mGluR1/5 and Homer 
1b/c expression in the rat striatum and medial prefrontal cortex (mPFC) would occur in 
response to an acute injection of amphetamine in vivo. 
Methods:  Following IACUC approval, adult male Wistar rats received an 
intraperitoneal injection of saline (n = 4) or amphetamine (5 mg/kg, n = 5).  Motor 
responses to amphetamine were monitored continuously following drug administration.  
For detecting gene expression, rats were anesthetized and sacrificed 1 h after saline or 
amphetamine injection.  Brains were removed, and the striatum, including the dorsal 
(caudate putamen) and ventral (nucleus accumbens) striatum, and mPFC were 
dissected.  Synaptic proteins were extracted for Western blot analysis of changes in 
mGluR1, mGluR5, and Homer1b/c protein levels with specific antibodies.  The density 
of immunoblots was measured using optical scanning.  Data were statistically analyzed 
using Student’s t-test (p<0.05). 
Results:  A single injection of amphetamine induced a typical increase in motor activity, 
confirming that a behaviorally active dose of the drug was used. At this dose, 
amphetamine markedly reduced mGluR5 protein levels in the striatum, while increasing 
mGluR5 protein levels in the mPFC.  Unlike mGluR5, mGluR1 protein expression in 
both the striatum and mPFC was not significantly altered in amphetamine-treated rats 
relative to saline-treated rats.  Homer1b/c protein levels in the two regions also 
remained stable in response to amphetamine administration.  Actin protein levels 
showed no difference between amphetamine- and saline-treated groups. 
Conclusion:  These data identify mGluR5 as a sensitive target of amphetamine.  Acute 
amphetamine exposure is able to alter striatal mGluR5 expression in a subtype- and 
region-specific manner. 
Discussion:  Amphetamine increases glutamate release in the striatum1 which can 
activate mGluRs in striatal neurons to produce drug effects.  Group I mGluRs have 
been demonstrated to undergo rapid desensitization following ligand stimulation of the 
receptor1.  Thus, our finding of a loss of synaptic mGluR5 after amphetamine suggests 
a previously unrecognized mechanism for such desensitization.  Of note, amphetamine 
has no effect on glutamate release in the mPFC1.  Future studies are needed to define 
the role of amphetamine-stimulated mGluR5 expression in this region. 
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